Cerebral Antibiotics Distribution After Acute Brain Injury

The aim of the study is to explore the distribution of antibiotics in the brain after an acute brain injury because brain infections treatment is still an health care problem.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bacterial Infection Bacterial Infections Bacterial Infections and Mycoses Brain Diseases Brain Injuries Brain Injury Central Nervous System Diseases Craniocerebral Trauma Infections Nervous System Diseases Trauma, Nervous System Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Poitiers University Hospital - 2 rue de la Milétrie - Réanimation chirugicale

Poitiers, 86021, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Acute brain injury
Patient who receive an antibiotic for an infection or prophylaxy
Glasgow coma score < 8

Exclusion criteria

Age < 18 years old
Pregnant woman
HCV, HIV, HBV infection

Treatment and study plan

Cefotaxime

Drug

Metronidazole

Drug

Ciprofloxacin

Drug

Fosfocine

Drug

Sponsors and collaborators

Lead sponsor

Poitiers University Hospital

Other

Registry information

Important dates

Study start: 2009
Primary completion: 2013
First posted: Feb 1, 2010
Registry last updated: Oct 11, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed